Pesticides & Agrochemicals · Founded 2019 · www.meghmani.com · BSE 543331 · NSE MOL · ISIN INE0CT101020
No Notes Added Yet
Business
Meghmani Organics Ltd. (MOL) is an India-based diversified chemical manufacturer. Its core business revolves around producing Agrochemicals (technical and formulations) and Pigments (phthalocyanine and azo pigments). The company is significantly backward integrated, allowing it to produce key intermediates for its end products. It serves both domestic and international markets, catering to agriculture, paints, coatings, plastics, and inks industries. MOL's business model focuses on cost-efficient manufacturing of generic agrochemicals and specialized pigments, leveraging its integrated facilities to maintain competitive pricing and consistent quality.
Revenue Mix
Meghmani Organics Ltd. primarily operates in two main segments:
Agrochemicals: This segment involves the manufacturing of a wide range of insecticides, herbicides, fungicides, and plant growth regulators, both technical grade and their formulations. It is a significant revenue contributor.
Pigments: This segment produces high-performance pigments, including Phthalocyanine Pigments (like Copper Phthalocyanine Crude, Alpha Blue, Beta Blue, Green) and Azo Pigments.
While specific current percentage breakdowns can fluctuate, the Agrochemicals segment typically forms the larger portion of the company's revenue.
Industry
MOL operates in the highly competitive Indian Pesticides & Agrochemicals and Pigments industries.
Agrochemicals: The Indian agrochemical industry is characterized by a mix of large multinational players and numerous domestic companies, often focusing on generic products. It's driven by agricultural output, monsoon patterns, and global food demand. MOL is positioned as a significant domestic player, particularly in generic agrochemicals, known for its cost-effectiveness, backward integration, and a diverse product portfolio. It competes with both Indian and global players in this space.
Pigments: The pigment industry is fragmented but with a few established global players. India is a major manufacturing hub for certain pigments. MOL is one of the leading manufacturers of phthalocyanine pigments in India, serving various industrial applications globally.
MOAT
Cost Leadership & Backward Integration: MOL's extensive backward integration into key intermediates for both agrochemicals and pigments allows it to control raw material costs, ensure consistent supply, and offer competitive pricing, which is a significant advantage in commodity-like markets.
Diversified Product Portfolio: A wide range of generic agrochemicals and a focused portfolio of pigments reduce dependency on single products or market cycles.
Scale and Manufacturing Expertise: Established large-scale manufacturing facilities and decades of experience in chemical synthesis contribute to operational efficiencies and quality consistency.
Global Presence & Customer Relationships: A strong export footprint and long-standing relationships with domestic and international customers provide market stability and growth avenues.
Growth Drivers
Increasing Global Food Demand: Growing global population and demand for food drive the need for agrochemicals to enhance crop yield and protection.
New Product Registrations & Launches: Introduction of new generic agrochemical technicals and formulations can open new market opportunities.
Capacity Expansion: Ongoing or planned capacity expansions in both segments (agrochemicals and pigments) will facilitate higher sales volumes.
Export Opportunities: Growing demand for cost-effective generic agrochemicals and pigments from developing and developed economies offers significant export growth potential.
Government Initiatives: Indian government initiatives to boost agriculture and domestic manufacturing (e.g., 'Make in India', PLI schemes) can indirectly benefit MOL.
Risks
Raw Material Price Volatility: Fluctuations in the prices of crude oil derivatives and other key chemical inputs can impact profitability, despite backward integration.
Regulatory & Environmental Compliance: Stringent environmental norms and regulations in India and export markets regarding chemical manufacturing and product use pose compliance risks and potential for increased costs.
Monsoon Dependency: The performance of the domestic agrochemical business is significantly influenced by the quantity and distribution of the monsoon in India.
Competition: Intense competition from domestic and international players, especially from China, can put pressure on pricing and margins.
Foreign Exchange Fluctuations: A significant portion of revenue comes from exports and raw materials are imported, making the company susceptible to currency volatility.
Product Ban Risk: Certain agrochemicals can be subject to bans or restrictions in various markets due to health or environmental concerns, impacting sales.
Management & Ownership
Meghmani Organics Ltd. is a promoter-driven company, led by the Meghmani Group. The founding families hold a significant stake and are actively involved in the management. They have a track record of expanding operations, backward integration, and navigating the complexities of the chemical industry. The company has a professional management team overseeing day-to-day operations and strategic growth initiatives. The ownership structure is typical of many Indian mid-sized chemical companies, with strong promoter control.
Outlook
Meghmani Organics Ltd. is positioned in defensive sectors (agro-chemicals) and specialty chemicals (pigments) that benefit from long-term demand trends. The company's strong backward integration and cost-efficient manufacturing capabilities provide a resilient operational base. Growth is likely to be driven by increasing global food demand, new product introductions, and capacity expansions. However, the business is exposed to risks such as raw material price volatility, environmental regulations, intense competition, and the cyclicality of the agricultural sector. A disciplined approach to capital expenditure, product diversification, and effective risk management will be crucial for sustained performance. The outlook remains cautiously optimistic, balancing the secular tailwinds for the chemical sector with inherent operational and market challenges.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 410 | 414 | 544 | 569 | 553 | 614 | 577 | 509 | 474 | 543 |
| Other Income | 9 | 9 | 12 | 9 | 14 | 17 | 28 | 15 | 37 | 12 |
| Total Income | 419 | 423 | 556 | 578 | 567 | 630 | 605 | 524 | 512 | 555 |
| Total Expenditure | 408 | 408 | 513 | 528 | 488 | 547 | 525 | 471 | 455 | 445 |
| Operating Profit | 11 | 15 | 43 | 50 | 79 | 83 | 80 | 53 | 57 | 110 |
| Interest | 2 | 11 | 26 | 13 | 19 | 29 | 24 | 18 | 20 | 13 |
| Depreciation | 23 | 23 | 25 | 30 | 29 | 30 | 30 | 30 | 29 | 30 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -14 | -19 | -9 | 7 | 31 | 24 | 26 | 5 | 7 | 67 |
| Provision for Tax | 4 | -3 | 0 | 12 | 11 | 12 | 15 | 8 | -1 | 19 |
| Profit After Tax | -18 | -17 | -9 | -4 | 20 | 13 | 12 | -4 | 8 | 48 |
| Adjustments | 0 | 0 | 0 | 0 | -0 | 0 | -0 | -0 | -0 | -0 |
| Profit After Adjustments | -18 | -17 | -9 | -4 | 20 | 13 | 12 | -4 | 8 | 48 |
| Adjusted Earnings Per Share | -0.7 | -0.7 | -0.4 | -0.2 | 0.8 | 0.5 | 0.5 | -0.1 | 0.3 | 1.9 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Net Sales | 700 | 1637 | 2498 | 2553 | 1566 | 2080 | 2174 | 2103 |
| Other Income | 131 | 25 | 98 | 96 | 41 | 44 | 96 | 92 |
| Total Income | 830 | 1661 | 2596 | 2649 | 1607 | 2124 | 2270 | 2196 |
| Total Expenditure | 595 | 1354 | 2120 | 2212 | 1587 | 1937 | 1998 | 1896 |
| Operating Profit | 235 | 307 | 476 | 437 | 21 | 187 | 273 | 300 |
| Interest | 18 | 11 | 11 | 66 | 50 | 69 | 92 | 75 |
| Depreciation | 22 | 51 | 63 | 77 | 92 | 108 | 119 | 119 |
| Exceptional Income / Expenses | 0 | 7 | 6 | 19 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 194 | 252 | 409 | 313 | -121 | 9 | 62 | 105 |
| Provision for Tax | 45 | 65 | 104 | 75 | -15 | 20 | 33 | 41 |
| Profit After Tax | 150 | 186 | 304 | 238 | -106 | -11 | 29 | 64 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 150 | 186 | 304 | 238 | -106 | -11 | 29 | 64 |
| Adjusted Earnings Per Share | 5.9 | 7.3 | 12 | 9.3 | -4.2 | -0.4 | 1.1 | 2.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 5% | -5% | 6% | 0% |
| Operating Profit CAGR | 46% | -15% | -2% | 0% |
| PAT CAGR | 0% | -50% | -31% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -34% | -11% | -14% | NA% |
| ROE Average | 2% | -2% | 7% | 9% |
| ROCE Average | 7% | 2% | 10% | 12% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 986 | 1173 | 1466 | 1669 | 1528 | 1515 | 1545 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 56 | 123 | 209 | 402 | 383 | 283 | 161 |
| Other Non-Current Liabilities | 63 | 64 | 88 | 98 | 66 | 83 | 88 |
| Total Current Liabilities | 552 | 614 | 1035 | 1030 | 1062 | 1204 | 1226 |
| Total Liabilities | 1657 | 1974 | 2798 | 3198 | 3039 | 3085 | 3021 |
| Fixed Assets | 481 | 634 | 911 | 1166 | 1152 | 1575 | 1494 |
| Other Non-Current Assets | 324 | 346 | 451 | 567 | 675 | 160 | 211 |
| Total Current Assets | 853 | 995 | 1436 | 1466 | 1212 | 1350 | 1315 |
| Total Assets | 1657 | 1974 | 2798 | 3198 | 3039 | 3085 | 3021 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 8 | 21 | 10 | 31 | 17 | 23 |
| Cash Flow from Operating Activities | 22 | 333 | 65 | 204 | 250 | 66 | 222 |
| Cash Flow from Investing Activities | -3 | -307 | -133 | -418 | -178 | 31 | -38 |
| Cash Flow from Financing Activities | -26 | -14 | 58 | 234 | -85 | -91 | -190 |
| Net Cash Inflow / Outflow | -8 | 12 | -10 | 21 | -14 | 6 | -7 |
| Closing Cash & Cash Equivalent | 8 | 21 | 10 | 31 | 17 | 23 | 16 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 5.88 | 7.33 | 11.97 | 9.35 | -4.17 | -0.42 | 1.13 |
| CEPS(Rs) | 6.76 | 9.33 | 14.43 | 12.38 | -0.54 | 3.84 | 5.81 |
| DPS(Rs) | 0 | 1.4 | 1.4 | 1.4 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 38.79 | 46.13 | 57.65 | 65.64 | 60.07 | 59.58 | 60.74 |
| Core EBITDA Margin(%) | 14.79 | 17.09 | 15.04 | 13.23 | -1.27 | 6.77 | 7.98 |
| EBIT Margin(%) | 30.2 | 15.91 | 16.68 | 14.7 | -4.48 | 3.74 | 6.96 |
| Pre Tax Margin(%) | 27.6 | 15.24 | 16.24 | 12.15 | -7.6 | 0.45 | 2.8 |
| PAT Margin (%) | 21.26 | 11.28 | 12.1 | 9.22 | -6.65 | -0.5 | 1.3 |
| Cash Profit Margin (%) | 24.44 | 14.35 | 14.59 | 12.21 | -0.87 | 4.62 | 6.68 |
| ROA(%) | 9.03 | 10.27 | 12.76 | 7.93 | -3.4 | -0.35 | 0.94 |
| ROE(%) | 15.16 | 17.27 | 23.07 | 15.16 | -6.63 | -0.7 | 1.88 |
| ROCE(%) | 17 | 19.59 | 24.73 | 17.02 | -2.94 | 3.35 | 6.67 |
| Receivable days | 239.14 | 96.26 | 69.15 | 75.5 | 109.43 | 86.49 | 102.2 |
| Inventory Days | 157.47 | 75.05 | 73.63 | 91.42 | 133.77 | 96.58 | 93.01 |
| Payable days | 209.36 | 116.01 | 114.77 | 123.53 | 167.63 | 150.52 | 150.09 |
| PER(x) | 0 | 0 | 8.71 | 8.3 | 0 | 0 | 32.43 |
| Price/Book(x) | 0 | 0 | 1.81 | 1.18 | 1.32 | 1.03 | 0.6 |
| Dividend Yield(%) | 0 | 0 | 1.34 | 1.8 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.4 | 0.16 | 1.25 | 1.08 | 1.81 | 1.13 | 0.75 |
| EV/Core EBITDA(x) | 1.19 | 0.87 | 6.58 | 6.32 | 135.97 | 12.61 | 5.98 |
| Net Sales Growth(%) | 0 | 133.96 | 52.66 | 2.17 | -38.64 | 32.78 | 4.53 |
| EBIT Growth(%) | 0 | 23.77 | 59.63 | -9.76 | -118.85 | 210.44 | 95.17 |
| PAT Growth(%) | 0 | 24.67 | 63.25 | -21.91 | -144.6 | 90 | 371.11 |
| EPS Growth(%) | 0 | 24.67 | 63.25 | -21.92 | -144.6 | 90 | 371.14 |
| Debt/Equity(x) | 0.27 | 0.22 | 0.34 | 0.49 | 0.55 | 0.55 | 0.47 |
| Current Ratio(x) | 1.55 | 1.62 | 1.39 | 1.42 | 1.14 | 1.12 | 1.07 |
| Quick Ratio(x) | 0.99 | 1.01 | 0.77 | 0.79 | 0.65 | 0.62 | 0.64 |
| Interest Cover(x) | 11.62 | 23.5 | 38.16 | 5.76 | -1.43 | 1.14 | 1.68 |
| Total Debt/Mcap(x) | 0 | 0 | 0.19 | 0.42 | 0.41 | 0.53 | 0.78 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 49.32 | 49.33 | 49.33 | 49.41 | 48.98 | 48.98 | 48.98 | 48.95 | 48.95 | 48.95 |
| FII | 1.39 | 2.22 | 1.89 | 1.81 | 1.94 | 1.48 | 1.33 | 1.34 | 0.91 | 0.84 |
| DII | 0.24 | 0.46 | 0.3 | 0.53 | 0.41 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Public | 49.05 | 47.98 | 48.48 | 48.25 | 48.67 | 49.5 | 49.65 | 49.66 | 50.1 | 50.17 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 12.54 | 12.54 | 12.55 | 12.57 | 12.46 | 12.46 | 12.46 | 12.45 | 12.45 | 12.45 |
| FII | 0.35 | 0.57 | 0.48 | 0.46 | 0.49 | 0.38 | 0.34 | 0.34 | 0.23 | 0.21 |
| DII | 0.06 | 0.12 | 0.08 | 0.13 | 0.1 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 12.47 | 12.2 | 12.33 | 12.27 | 12.38 | 12.59 | 12.63 | 12.63 | 12.74 | 12.76 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +5% | -5% | +6% | — |
| Operating Profit CAGR | +46% | -15% | -2% | — |
| PAT CAGR | — | -50% | -31% | — |
| Share Price CAGR | -34% | -11% | -14% | — |
| ROE Average | +2% | -2% | +7% | +9% |
| ROCE Average | +7% | +2% | +10% | +12% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 49.32 | 49.33 | 49.33 | 49.41 | 48.98 | 48.98 | 48.98 | 48.95 | 48.95 | 48.95 |
| FII | 1.39 | 2.22 | 1.89 | 1.81 | 1.94 | 1.48 | 1.33 | 1.34 | 0.91 | 0.84 |
| DII | 0.24 | 0.46 | 0.3 | 0.53 | 0.41 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Public | 49.05 | 47.98 | 48.48 | 48.25 | 48.67 | 49.5 | 49.65 | 49.66 | 50.1 | 50.17 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 12.54 | 12.54 | 12.55 | 12.57 | 12.46 | 12.46 | 12.46 | 12.45 | 12.45 | 12.45 |
| FII | 0.35 | 0.57 | 0.48 | 0.46 | 0.49 | 0.38 | 0.34 | 0.34 | 0.23 | 0.21 |
| DII | 0.06 | 0.12 | 0.08 | 0.13 | 0.1 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 12.47 | 12.2 | 12.33 | 12.27 | 12.38 | 12.59 | 12.63 | 12.63 | 12.74 | 12.76 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.